Indian pharmaceutical company Marksans Pharma Limited is recalling Metformin Hydrochloride Extended-Release Tablets because its levels of NDMA, a “probable human carcinogen,” were higher than the acceptable daily intake limit, according to an FDA recall.
More Stories
LGBTQ-inclusive books are hard to find. So these groups started sending them to schools.
At least six arrested as ‘Stop the Steal’ protesters and counter-protesters clash in Washington, DC
Two LA County sheriff’s deputies involved in the fatal shooting of Andres Guardado relieved of duties following unrelated investigation